Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Extends Employment Agreement of Chief Executive Officer
Integra LifeSciences Extends Employment Agreement of Chief Executive Officer PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Stuart M. Essig, Integra's President and Chief Executive Officer, has renewed his employment
View HTML
Toggle Summary Integra LifeSciences Announces Second Quarter 2004 Financial Results
Integra LifeSciences Announces Second Quarter 2004 Financial Results PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.5 million, or $0.24 per share, for the second quarter of 2004, compared to net income of $5.4
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--July 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra Epilepsy™ Products Featured at the 2004 National Teaching Institute & Critical Care Exposition
Integra Epilepsy(TM) Products Featured at the 2004 National Teaching Institute & Critical Care Exposition PLAINSBORO, N.J., May 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it is featuring its recently launched Integra Epilepsy™ products at
View HTML
Toggle Summary Integra LifeSciences Announces Results of Stockholders' Vote at Annual Meeting
Integra LifeSciences Announces Results of Stockholders' Vote at Annual Meeting PLAINSBORO, N.J., May 17, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced at the annual meeting of stockholders today that David C. Auth, Ph.D., Keith Bradley, Ph.D., Richard E.
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of MAYFIELD® and BUDDE® Cranial Stabilization Product Lines
Integra LifeSciences Announces Acquisition of MAYFIELD(R) and BUDDE(R) Cranial Stabilization Product Lines PLAINSBORO, N.J., May 10, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the MAYFIELD® Cranial Stabilization and
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Berchtold Medizin-Elektronik GmbH
Integra LifeSciences Announces Acquisition of Berchtold Medizin-Elektronik GmbH PLAINSBORO, N.J., May 4, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired Berchtold Medizin-Elektronik GmbH from Berchtold Holding GmbH.
View HTML
Toggle Summary Integra NeuroSciences™ Launches 5 by 7-inch DuraGen Plus™ Dural Graft Matrix
Integra NeuroSciences(TM) Launches 5 by 7-inch DuraGen Plus(TM) Dural Graft Matrix PLAINSBORO, N.J., May 4, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has launched a new 5 by 7-inch size of the DuraGen Plus™ Dural Graft
View HTML
Toggle Summary Integra LifeSciences Launches LICOX® PMO Catheter
Integra LifeSciences Launches LICOX(R) PMO Catheter PLAINSBORO, N.J., May 3, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the LICOX® PMO, a next-generation catheter and introducer for use with the Integra LICOX®
View HTML
Toggle Summary Integra LifeSciences Announces First Quarter 2004 Financial Results
Integra LifeSciences Announces First Quarter 2004 Financial Results PLAINSBORO, N.J., April 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.4 million, or $0.24 per share, for the first quarter of 2004, compared to net income of $5.4
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, April 28 to Discuss First Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, April 28 to Discuss First Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--April 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra LifeSciences Supports Study On Spinal Cord Injuries
Integra LifeSciences Supports Study On Spinal Cord Injuries PLAINSBORO, N.J., April 2, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced its participation in a study published last month in the European Journal of Neuroscience.
View HTML
Toggle Summary Integra LifeSciences Features Recently Launched INTEGRA™ Bilayer Matrix Wound Dressing At American Burn Association Meeting
Integra LifeSciences Features Recently Launched INTEGRA(TM) Bilayer Matrix Wound Dressing At American Burn Association Meeting PLAINSBORO, N.J., March 25, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it is featuring its recently launched INTEGRA™
View HTML
Toggle Summary Integra LifeSciences' JARIT Surgical Instruments Launches Redmond/R&B Instruments at 2004 AORN Congress
Integra LifeSciences' JARIT Surgical Instruments Launches Redmond/R&B Instruments at 2004 AORN Congress PLAINSBORO, N.J., March 23, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that JARIT® Surgical Instruments launched the Redmond/R&B Surgical
View HTML
Toggle Summary Integra LifeSciences Reports Record Operating Earnings and Revenues for the Fourth Quarter and Full Year 2003
Integra LifeSciences Reports Record Operating Earnings and Revenues for the Fourth Quarter and Full Year 2003 PLAINSBORO, N.J., Feb. 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $9.2 million, or $0.30 per share, for the fourth quarter
View HTML